home / stock / lly / lly news


LLY News and Press, Eli Lilly and Company From 02/06/24

Stock Information

Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com

Menu

LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...

LLY - Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's Potential

2024-02-06 19:32:41 ET Summary Madrigal Pharmaceuticals is leading the race to secure approval for its drug Resmetirom to treat NASH, now known as MASH, a form of fatty liver disease. Eli Lilly's drug tirzepatide, which has already secured approvals for Type 2 diabetes and obesity...

LLY - Eli Lilly and Co (LLY) Q4 2023 Earnings Conference Call Transcript

2024-02-06 16:47:04 ET Eli Lilly and Co (LLY) Q4 2024 Earnings Conference Call February 06, 2024, 10:00 AM ET Company Participants Joe Fletcher - SVP, IR David Ricks - Chairman, CEO & President Anat Ashkenazi - EVP & CFO Daniel Skovronsky - Chief Scie...

LLY - Catalent ticks lower amid report Indiana plant may have quality issues

2024-02-06 16:16:24 ET More on Catalent Catalent: Debt Remains An Overhang Catalent, Inc. (CTLT) Q1 2024 Earnings Call Transcript Catalent, Inc. 2024 Q1 - Results - Earnings Call Presentation Lilly reportedly worried about impact of Catalent/Novo deal ...

LLY - Lilly reportedly worried about impact of Catalent/Novo deal

2024-02-06 13:23:49 ET More on Catalent, Eli Lilly, etc. Eli Lilly and Company 2023 Q4 - Results - Earnings Call Presentation Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Novo Nordisk A/S (NVO) Q4 2023 Earnings Call Transcript ...

LLY - Eli Lilly hurts NASH drug developers after mid-stage win for obesity therapy

2024-02-06 12:58:10 ET More on Akero Therapeutics, 89bio, etc. Biotech And Pharma Diversification Pays Off Sagimet: Additional Upside Possible After Latest NASH Data Release Madrigal Pharmaceuticals: A Deeper Look At A Looming NASH Play Karuna’s KarXT ...

LLY - Why Eli Lilly Stock Jumped as Much as 5.1% Today Then Gave Up Its Gains

2024-02-06 11:41:40 ET Shares of Eli Lilly (NYSE: LLY) jumped as much as 5.1% on Tuesday. However, as of 11:37 a.m. ET, the big pharma stock was down by 0.5%. The initial spike came after Lilly announced its 2023 fourth-quarter and full-year results. The company reported Q4 reve...

LLY - 6 stocks to watch on Tuesday: Spotify, Eli Lilly, Chipotle, DocuSign and more

2024-02-06 09:15:00 ET U.S. stock index futures on Tuesday pointed to a slightly higher open, as market participants geared up for a host of Federal Reserve speakers through the day. The central bank last week pushed back against rate cut expectations. Here are some stocks to watch on T...

LLY - US Companies Moving the Markets, Morning edition
Tue, Feb 06, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Phunware Inc. (PHUN) rose 19.9% to $0.41 on volume of 260,182,609 shares Palantir Technologies Inc. Class A (PLTR) fell 1.8% to $16.72 on volume of 167,698,349 shares PROSHARES TRUST (SQQQ) rose 0.5% to $11.78 on volume of 155,646,888...

LLY - U.S. Futures Little Changed

S&P 500 futures hovered around the flatline Tuesday following a selloff spurred by higher bond yields and worries that the Federal Reserve may not cut rates as much as Wall Street had hoped. Futures for the Dow Jones Industrials index subsided 13 points to 38,453. Futures for the S&am...

LLY - Eli Lilly in charts: Verzenio and Mounjaro drive revenue growth, while Humalog and Trulicity decline

2024-02-06 07:28:18 ET More on Eli Lilly, Eli Lilly and Company, etc. Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly beats in Q4 a...

Previous 10 Next 10